Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders
about
sameAs
Modulation of Fear Extinction by Stress, Stress Hormones and Estradiol: A Review.D-Cycloserine in Neuropsychiatric Diseases: A Systematic ReviewCombined Neuropeptide S and D-Cycloserine Augmentation Prevents the Return of Fear in Extinction-Impaired Rodents: Advantage of Dual versus Single Drug Approaches.Fluoxetine Facilitates Fear Extinction Through Amygdala EndocannabinoidsEmerging drugs for the treatment of anxietyStress and Fear Extinction.Voluntary exercise during extinction of auditory fear conditioning reduces the relapse of fear associated with potentiated activity of striatal direct pathway neuronsAn Overview of Translationally Informed Treatments for Posttraumatic Stress Disorder: Animal Models of Pavlovian Fear Conditioning to Human Clinical TrialsThe Combination of Long-term Ketamine and Extinction Training Contributes to Fear Erasure by Bdnf Methylation.Potential of Oxytocin in the Treatment of SchizophreniaEpigenetic mechanisms during ageing and neurogenesis as novel therapeutic avenues in human brain disorders.An Integrated Neuroscience Perspective on Formulation and Treatment Planning for Posttraumatic Stress Disorder: An Educational Review.Neuroenhancement of Exposure Therapy in Anxiety Disorders.Prefrontal inputs to the amygdala instruct fear extinction memory formation.Impaired Contextual Fear Extinction Learning is Associated with Aberrant Regulation of CHD-Type Chromatin Remodeling Factors.Finding translation in stress research.Pancreatic polypeptide and its central Y4 receptors are essential for cued fear extinction and permanent suppression of fear.Involvement of CRFR1 in the Basolateral Amygdala in the Immediate Fear Extinction DeficitEnhancing dopaminergic signaling and histone acetylation promotes long-term rescue of deficient fear extinction.A Review of Oxytocin's Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia.Inhibition of serotonin transporters disrupts the enhancement of fear memory extinction by 3,4-methylenedioxymethamphetamine (MDMA).Acute exercise enhances the consolidation of fear extinction memory and reduces conditioned fear relapse in a sex-dependent manner.Diminishing fear: Optogenetic approach toward understanding neural circuits of fear control.Fear Memory.Drugs, games, and devices for enhancing cognition: implications for work and society.Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond.A Meta-Analysis of D-Cycloserine in Exposure-Based Treatment: Moderators of Treatment Efficacy, Response, and Diagnostic Remission.On the Road to Translation for PTSD Treatment: Theoretical and Practical Considerations of the Use of Human Models of Conditioned Fear for Drug Development.L-type Ca2+ channels in mood, cognition and addiction: integrating human and rodent studies with a focus on behavioural endophenotypes.Bridging the Gap: Towards a cell-type specific understanding of neural circuits underlying fear behaviorsAnimal Models of PTSD: A Critical Review.Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders.Integrating NIMH Research Domain Criteria (RDoC) into PTSD Research.Oxytocin and opioid addiction revisited: old drug, new applications.Emotional Modulation of Learning and Memory: Pharmacological Implications.From Gene to Behavior: L-Type Calcium Channel Mechanisms Underlying Neuropsychiatric Symptoms.Treating breathlessness via the brain: changes in brain activity over a course of pulmonary rehabilitation.Impaired Fear Extinction Due to a Deficit in Ca2+ Influx Through L-Type Voltage-Gated Ca2+ Channels in Mice Deficient for Tenascin-C.Verapamil Blocks Scopolamine Enhancement Effect on Memory Consolidation in Passive Avoidance Task in Rats.Morphological and physiological properties of CCK/CB1R-expressing interneurons in the basal amygdala.
P2860
Q26767636-9C544FC4-5E3E-425B-B043-4935EA807C00Q26781321-84CB1DDD-633F-47D2-82DF-D89B56E39E41Q27300710-5A57639D-91AA-407F-A996-00BE58B9F62DQ27310769-9ED69C16-6699-4BE2-AE54-CF5A85849889Q28083141-3B280361-21D4-489D-8332-55EBC9FDD177Q30366954-AEB5B06C-5B63-451F-8EF4-51B10260EC76Q30371197-0C64A926-E535-4413-8255-91F58C1217F4Q30375098-6EFF28D3-1AB1-41C2-AF4C-403F85A5DE54Q33583121-14937ABD-A76B-480D-87D4-C4577CC23701Q33761384-12D40278-3A0F-4E3A-BC79-E3996818AE0DQ33858861-CFBD48E9-E70C-4103-A2F8-3011EFA7D6A0Q33891691-ADBDF611-867C-4C05-98E0-912D59D5BAB2Q35985350-407E2A9C-D309-4315-A803-8D3BE8A1F68FQ36201622-F8D2650C-47E6-49DC-BAEE-4CBE6B433736Q36290178-504D19F2-8532-4966-A243-7DF76AAD2408Q36409621-E2B41391-F991-4554-8036-51B5F9F0140FQ36941269-0CC139E8-4D34-4475-8C34-9841AD212952Q37389559-066FF25C-CDD3-4A71-9A1C-DD2827D9B24FQ37650463-D19A0FC5-23FD-421E-B0FC-A1EB3AFD149DQ38593718-C56FE914-E1FA-40D3-A0D8-BD881AA3810BQ38652284-6C8C7D9A-9D04-4BE7-BA70-75D084CC1497Q38674849-44E9EB4A-2144-483C-986F-960DC880A325Q38684102-57D6714A-249E-4346-AF8B-75718C18B481Q38777375-FCA1CD09-05DB-4CFC-BA12-7B27150671A0Q38797653-88AF5B40-B071-4AFD-BC24-F63C12907AA2Q38832608-B2245CA7-CEC3-4261-A039-C967917DEABBQ38851779-59A12956-FECE-4EB6-8F55-BF0A6CB9E887Q38852116-BFBC92B3-96D2-4E19-B0B2-30746ACEAE26Q38903556-B948E303-D5A1-4D1C-8357-1C9CB2D3CB4DQ38911889-5AC0D03B-D28B-41A1-9E65-57EFBE6608E8Q39077821-A2F969E0-A7DE-4706-84F1-81833A2D5FECQ39166556-244825C3-723D-4C0E-BCC3-50F0EB37A3C0Q39200073-9A787C93-9821-4FB6-9DF3-AC082C6734F1Q39221067-948B4F41-EA2C-44B1-8526-EBA737B6B53EQ39249414-E28B93E2-AC1E-40C8-A644-912E7B409E20Q39301735-9CBCF26B-A872-4E97-A610-B96C4D5E8512Q40050467-1333540F-B1DD-4FC4-8986-C71A06DCF018Q41205004-B54EADB1-1C42-4F23-80B5-9FD18816BBCDQ41527014-A12E1C01-531A-4744-93AD-9D60E730654FQ42508308-55E1F2B3-6F50-4DED-8598-1A084282E0E5
P2860
Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Pharmacology of cognitive enha ...... y and trauma-related disorders
@ast
Pharmacology of cognitive enha ...... y and trauma-related disorders
@en
Pharmacology of cognitive enha ...... y and trauma-related disorders
@nl
type
label
Pharmacology of cognitive enha ...... y and trauma-related disorders
@ast
Pharmacology of cognitive enha ...... y and trauma-related disorders
@en
Pharmacology of cognitive enha ...... y and trauma-related disorders
@nl
prefLabel
Pharmacology of cognitive enha ...... y and trauma-related disorders
@ast
Pharmacology of cognitive enha ...... y and trauma-related disorders
@en
Pharmacology of cognitive enha ...... y and trauma-related disorders
@nl
P2093
P2860
P921
P3181
P1476
Pharmacology of cognitive enha ...... y and trauma-related disorders
@en
P2093
C Schmuckermair
P2860
P304
P3181
P356
10.1016/J.PHARMTHERA.2014.12.004
P407
P5008
P577
2015-05-01T00:00:00Z